Buffington Mohr McNeal raised its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 76,746 shares of the company’s stock after buying an additional 328 shares during the period. […] Read this story